Stocks
Allogene Therapeutics (ALLO) FCF/share US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| FCF/share, rub | -1.86 | -1.50 | -1.52 | -1.58 | -1.52 | -1.35 | |||
| Changes by years, y/y, % | +13% | -19% | +1% | +4% | -3% | -1.6% | |||
Allogene Therapeutics. FCF/share, rub
Allogene Therapeutics. FCF/share, changes, %
Allogene Therapeutics (ALLO) FCF/share US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| FCF/share, rub | -0.47 | -0.42 | -0.33 | -0.32 | -0.33 | -1.35 | ||
| Changes by years, y/y, % | -6% | +38% | -1% | -28% | -29% | |||
| Changes by quarters, q/q, % | +6% | -10% | -22% | -3% | +3% | |||
